# Tecovirimat in Non-hospitalized Patients With Monkeypox

> **NCT05534165** · PHASE3 · SUSPENDED · sponsor: **Marina Klein** · enrollment: 120 (estimated)

## Conditions studied

- Monkeypox

## Interventions

- **DRUG:** Tecovirimat
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05534165
- **Lead sponsor:** Marina Klein
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2023-08-14
- **Primary completion:** 2025-03-13
- **Final completion:** 2026-03-31
- **Target enrollment:** 120 (ESTIMATED)
- **Why stopped:** The recommendations of the Data Safety Monitoring Committee, based on the results of the STOMP Study (NCT05534984).
- **Last updated:** 2026-03-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05534165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05534165, "Tecovirimat in Non-hospitalized Patients With Monkeypox". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05534165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*